Company Acerus Pharmaceuticals Corporation Toronto S.E.
Equities
ASP
CA00444G4051
Pharmaceuticals
Business Summary
Number of employees: 14
Managers
Managers | Title | Age | Since |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 18-04-30 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 20-07-16 | |
Philippe Savard
LAW | General Counsel | - | 16-07-03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 13-09-08 |
Borys Chabursky
BRD | Director/Board Member | - | 15-12-19 |
Edward Gudaitis
CEO | Chief Executive Officer | - | 18-04-30 |
Stephen Gregory
BRD | Director/Board Member | - | 11-07-13 |
Geoff Cotton
BRD | Director/Board Member | - | 20-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,702,297 | 662,312 ( 8.599 %) | 0 | 8.599 % |
Company contact information
Acerus Pharmaceuticals Corp.
7025 Langer Drive Suite 205
L5N 0E8, Mississauga
+
http://www.aceruspharma.comSector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |